Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: A study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors

American Journal of Neuroradiology

Volumn 23, Issue 1, 2002, Pages 15-18

  Zhang, Tian ^a   Matsumura, Akira ^a   Yamamoto, Tetsuya ^a   Yoshida, Fumiyo ^a   Nose, Tadao ^a   Shimojo, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG SELECTIVITY; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; METABOLIC CLEARANCE RATE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, INBRED F344; SPECTROPHOTOMETRY, ATOMIC;

EID: 0036155746     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Liver III: Gadolinium based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/diemeg)
2. Interim results of phase II clinical testing of gadobenate dimeglumine
3. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)
4. Clinical late phase III trials of multihance (Gd-BOPTA) for the magnetic resonance imaging of liver tumor in Japan
5. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers
6. General toxicity study of gadobenate dimeglumine formulation (E7155) (4): 4-week repeated dose intravenous toxicity study followed by 4-week recovery period in dogs
7. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155)(4): Study of embryo-fetal toxicity in rabbits by intravenous administration
8. Ex-vivo MR imaging of liver intracellular contrast agents
9. Neutron capture therapy with Gd-DTPA in tumor-bearing rats
10. Boron-, gadoliniumporphyrin derivatives for neutron capture therapy
11. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumor with the MRI contrast agent Gadobutrol
12. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy
13. Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice
14. Radiation effect of gadolinium neutron capture reactions on survival of Chinese hamster cells
15. Molecular mechanisms for hepatic uptake of magnetic resonance imaging contrast agent